Closed a series of anti-drug major Cipla all patents for cancer drugs with a Chinese partner is set to ink a deal. In the next two years for drugs are expected to begin. CNBC TV 18 - Archi Damania and Priyanka Ghosh's report. Cipla than the market currently available at affordable prices to launch their
anti-cancer drug has promise. Goal for the next two to two and a half years Cipla Chairman and Managing Director Joseph K Hamied said, we launch one biotech product within the next two to two and the Chinese probably are planning to tie, "a half years Our cancer drug marketed as organic. Should be " Is in the process of upgrading its existing production facilities company. API is a new plant being set up in Bangalore, aggressive expansion of its facilities plan with Kurkumbh and Patalganga. Research and development activities and its Vikhroli are at Patalganga plant expansion mode. No wonder Cipla is amended capex targets. But this Hamied said, "During the coming two years, additional capital expenditure of Rs 500-600 crore is required. Obviously, with this, working capital requirements have increased from about Rs 300 crore annually. Shall"
anti-cancer drug has promise. Goal for the next two to two and a half years Cipla Chairman and Managing Director Joseph K Hamied said, we launch one biotech product within the next two to two and the Chinese probably are planning to tie, "a half years Our cancer drug marketed as organic. Should be " Is in the process of upgrading its existing production facilities company. API is a new plant being set up in Bangalore, aggressive expansion of its facilities plan with Kurkumbh and Patalganga. Research and development activities and its Vikhroli are at Patalganga plant expansion mode. No wonder Cipla is amended capex targets. But this Hamied said, "During the coming two years, additional capital expenditure of Rs 500-600 crore is required. Obviously, with this, working capital requirements have increased from about Rs 300 crore annually. Shall"For Further Details Visit At:www.moneycontrol.com/india/news/cnbc-tv18-comments/cipla-to-ink-patent-dealchinese-partner-/412963
No comments:
Post a Comment